DNTH vs IT · rev $6.2M vs P/E 16, rev $6.27B
Dianthus Therapeutics Inc. (DNTH) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
DNTH currently screens at market cap $4.40B. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the DNTH and IT stock pages for the full models.
Not investment advice.